Group lead: David Fitzmaurice
The HAPS Cardiovascular group has historically been very successful with large grants awarded from MRC and NIHR around atrial fibrillation diagnosis and treatment, antithrombotic treatment and service delivery, and latterly heart failure diagnosis and management. Current activity has developed from these areas into overlapping themes of stroke prevention and management, behavioural change, and rehabilitation.
The current cardiovascular research programme can be categorised into the following themes:
1. Improving the standards of care associated with anticoagulation therapy. This includes original work around service delivery, including patient self-management, and will shortly involve investigating the impact of novel therapeutic agents across the whole health economy.
2. Heart Failure. There is an on-going programme of work around improving diagnosis and management of heart failure, with new work including the interaction of chronic kidney disease with heart failure.
3. Epidemiology. This is a cross-cutting theme with special focus on the epidemiology of ischaemic heart disease, including the evaluation of population based risk scores. This work forms two themes from the Birmingham and Black Country CLAHRC and has extensive collaborations in both China and Iran.
4. Improving the prevention and treatment of thrombo-embolic disease. This programme of work is underpinned by an NIHR programme grant and includes strands investigating why prevention is often overlooked, as well as a randomised trial of extended therapy for idiopathic venous thromboembolism.
Research group members...